Bristol-Myers Squibb Company

NYSE: BMY
$54.86
-$0.43 (-0.8%)
Real Time Data Delayed 15 Min.

BMY Articles

October 24, 2016: Here are four stocks trading with relatively heavy volume among 36 equities making new 52-week lows in Monday’s session. On the NYSE, advancers led decliners by about 3 to 2 and...
Earnings season is now in full swing, and we have put together a preview of Bristol-Myers, AbbVie and some of the other top players in the health care sector.
October 17, 2016: Here are four stocks trading with relatively heavy volume among 71 equities making new 52-week lows in Monday’s session. On the NYSE, decliners led advancers by about 3 to 2 and...
October 13, 2016: Here are four stocks trading with relatively heavy volume among 80 equities making new 52-week lows in Thursday’s session. On the NYSE, decliners led advancers by 2 to 1 and on...
The top analyst upgrades, downgrades and initiations seen on Thursday morning include Charles Schwab, Merck, Nokia, Viacom, Waste Management and Windstream.
The September 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short interest was mixed.
October 11, 2016: Here are four stocks trading with relatively heavy volume among 69 equities making new 52-week lows in Tuesday’s session. On the NYSE, decliners led advancers by about 7 to 1 and...
October 7, 2016: Here are four stocks trading with relatively heavy volume among 26 equities making new 52-week lows in Monday’s session. On the NYSE, advancers led decliners by about 2.5 to 1 and...
On Monday morning, Merck, Mylan and Bristol-Myers Squibb made substantial runs, either up or down.
October 3, 2016: Here are four stocks trading with relatively heavy volume among 29 equities making new 52-week lows in Monday’s session. Wells Fargo & Co. (NYSE: WFC) lost about 1.6% Monday to...
September 28, 2016: Here are four stocks trading with relatively heavy volume among 33 equities making new 52-week lows in Wednesday’s session. NYSE advancers led decliners by nearly 7 to 3 and...
The September 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has increased.
Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to drive them forward.
The August 31 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has significantly decreased.
September 12, 2016: Here are four stocks trading with relatively heavy volume among 56 equities making new 52-week lows in Monday’s session. NYSE advancers led decliners by more than 2 to 1 and...